Roche beats revenue estimates, shares slip as copycats eat into Xolair sales
By Patrick Wingrove and Marleen Kaesebier ZURICH/ LONDON, Oct 22 – Swiss drugmaker Roche beat third-quarter sales expectations on Thursday, supported by steady demand for key medicines such as Ocrevus to buy time as it looks abroad to restock a pipeline facing looming patent expiries. Group revenue

















